Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Non-Current Deferred Tax Liability (2016 - 2025)

CV Sciences (CVSI) has disclosed Non-Current Deferred Tax Liability for 11 consecutive years, with $7000.0 as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability rose 75.0% to $7000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7000.0 through Dec 2025, up 75.0% year-over-year, with the annual reading at $7000.0 for FY2025, 75.0% up from the prior year.
  • Non-Current Deferred Tax Liability hit $7000.0 in Q4 2025 for CV Sciences, up from $4000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $592000.0 in Q4 2021 to a low of $4000.0 in Q4 2024.
  • Historically, Non-Current Deferred Tax Liability has averaged $87200.0 across 5 years, with a median of $19000.0 in 2024.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: surged 277.07% in 2021 and later plummeted 97.18% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $592000.0 in 2021, then tumbled by 59.46% to $240000.0 in 2022, then tumbled by 40.83% to $142000.0 in 2023, then tumbled by 97.18% to $4000.0 in 2024, then skyrocketed by 75.0% to $7000.0 in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for CVSI at $7000.0 in Q4 2025, $4000.0 in Q3 2025, and $4000.0 in Q2 2025.